Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec 10;11(12):1988.
doi: 10.3390/cancers11121988.

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

Affiliations
Review

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

Myriem Boufraqech et al. Cancers (Basel). .

Abstract

Recent advances in high-throughput molecular and multi-omics technologies have improved our understanding of the molecular changes associated with thyroid cancer initiation and progression. The translation into clinical use based on molecular profiling of thyroid tumors has allowed a significant improvement in patient risk stratification and in the identification of targeted therapies, and thereby better personalized disease management and outcome. This review compiles the following: (1) the major molecular alterations of the genome, epigenome, transcriptome, proteome, and metabolome found in all subtypes of thyroid cancer, thus demonstrating the complexity of these tumors and (2) the great translational potential of multi-omics studies to improve patient outcome.

Keywords: genomic; methylation; microRNA; proteomic; thyroid cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Genetic alterations involved in thyroid cancer initiation or progression. Abbreviations: N = normal thyroid, FA = follicular adenoma, FTC = follicular thyroid cancer, PTC = papillary thyroid cancer, PDTC = poorly-differentiated thyroid cancer, and ATC = anaplastic thyroid cancer.

References

    1. Davies L., Welch H.G. Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. 2014;140:317–322. doi: 10.1001/jamaoto.2014.1. - DOI - PubMed
    1. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164–2167. doi: 10.1001/jama.295.18.2164. - DOI - PubMed
    1. Kent W.D., Hall S.F., Isotalo P.A., Houlden R.L., George R.L., Groome P.A. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ. 2007;177:1357–1361. doi: 10.1503/cmaj.061730. - DOI - PMC - PubMed
    1. Vaccarella S., Franceschi S., Bray F., Wild C.P., Plummer M., Dal Maso L. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N. Engl. J. Med. 2016;375:614–617. doi: 10.1056/NEJMp1604412. - DOI - PubMed
    1. Enewold L., Zhu K., Ron E., Marrogi A.J., Stojadinovic A., Peoples G.E., Devesa S.S. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomark. Prev. 2009;18:784–791. doi: 10.1158/1055-9965.EPI-08-0960. - DOI - PMC - PubMed

LinkOut - more resources